Anaplastic Multiple Myeloma: A Report of a Rare Case with CD38 and CD117 Positivity
PDF

Case report

Anaplastic Multiple Myeloma: A Report of a Rare Case with CD38 and CD117 Positivity

Acta Haematol Oncol Turc 2023;56(3):272-276 DOI: 10.5505/aot.2023.43925
, , ,
PDF
Permissions

Abstract

Anaplastic multiple myeloma (AMM), which comprises anaplastic multiple myeloma and anaplastic plasmacytoma, is a rare illness that aggressively advances as a morphological subtype of multiple myeloma (MM). It has a poor prognosis and is believed to be particularly resistant to treatment. In this case report, we presented a 66-year-old woman diagnosed with AMM. The anaplastic morphology of MM may pose a diagnostic challenge. The need for a multidisciplinary approach to detect hematological neoplasms is highlighted in this example. For AMM instances, prompt radiographic, flowcytometry, and histological examination may assist guide effective treatment strategies.

Keywords: Anaplastic myeloma, multiple myeloma, monoclonal antibody